Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox FCT extension study
NCT02720536Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of deferasirox in hemochromatosis (HH), sponsored by Novartis. Started Aug 2016; status: completed.
02
Drugs
deferasirox
03
Conditions
hemochromatosis (HH)
Beyond the preview
Go deeper on NCT02720536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720536.